Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glycosyn LLC
Woburn, Massachusetts, United Statesglycosynllc.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Glycosyn develops proprietary fermentation technologies to produce human milk oligosaccharides at scale. Their products are intended to enhance gut health and immune function in infants, children, and adults. The company targets a range of infectious and chronic diseases but has not publicly disclosed clinical trial results or late-stage development programs.
- Therapeutic areas
- PulmonologyMetabolic DisordersGastroenterologyInfectious Diseases
- Modalities
- Human Milk Oligosaccharides (hMOS)Bioactive sugars
- Industry
- Biotech
Beyond the preview
Go deeper on Glycosyn LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glycosyn LLC.